Adenocarcinoma of Colon Active Not Recruiting Phase 2 Trials for Pertuzumab (DB06366)

Also known as: Adenocarcinoma Colon / Colon Adenocarcinoma / Adenocarcinoma of the Colon

Indication	Status	Phase
DBCOND0060083 (Adenocarcinoma of Colon)	Active Not Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03365882	S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery	Treatment	Camptothecin (DB04690) Cetuximab (DB00002) Irinotecan (DB00762) Pertuzumab (DB06366) Trastuzumab (DB00072)